Iodine Software, a leading healthcare AI company, announced a strategic growth investment from Advent International, one of the largest and most experienced global private equity investors. Advent will acquire a significant stake in Iodine in a transaction that values the business at over $1 billion. Bain Capital Ventures and Silversmith Capital Partners, which invested in the Company in 2018, will remain shareholders.
Read full press release from Iodine Software.